Introducing Assure® Titanium BGMS for Effective Diabetes Management
ARKRAY has proudly launched the Assure® Titanium Blood Glucose Monitoring System (BGMS), an innovative solution aimed at enhancing diabetes management in post-acute and long-term care environments. This exciting development promises to set a new standard for healthcare facilities by providing advanced tools that ensure reliable glucose monitoring.
Unmatched Accuracy and Performance in Diabetes Care
The Assure® Titanium BGMS has been validated through extensive clinical studies and earned FDA clearance based on rigorous guidelines. Its proven accuracy and reliability make it an essential tool for skilled nursing facilities, endocrinology clinics, and other post-acute providers who are focused on advancing their diabetes management protocols.
Innovative Features for Enhanced Operational Efficiency
Key to the success of the Titanium BGMS is its unique 24-hour quality control (QC) lockout feature. This ensures that daily QC testing is performed, permitting glucose readings only from verified devices. By adhering to the latest clinical best practices, this feature not only reduces the risk of errors but also helps facilities comply with regulatory standards effectively.
A Commitment to Better Patient Care
Toshio Serizawa, COO of ARKRAY USA, expressed that the Assure® Titanium reflects a serious commitment to advancing point-of-care glucose testing, particularly in long-term care settings. The integration of compliance features and error-reduction safeguards showcases ARKRAY's dedication to supporting caregivers and enhancing the quality of daily diabetes management for residents.
Comprehensive Support for Seamless Integration
ARKRAY USA is dedicated to ensuring that the integration of the Titanium BGMS into existing workflows is smooth and efficient. To facilitate this, ARKRAY offers comprehensive training and implementation services designed to support healthcare providers during the transition. This commitment to support ensures facilities can leverage the benefits of the Assure® Titanium system immediately.
About ARKRAY USA
ARKRAY USA, Inc. is a division of ARKRAY, a renowned global leader in healthcare product development based in Kyoto, Japan. With over fifty years of experience, ARKRAY has pioneered innovative healthcare solutions contributing to the well-being of individuals around the world. Operating in more than 80 countries, ARKRAY has established itself as a market leader particularly in diabetes management within professional healthcare markets in the U.S.
Frequently Asked Questions
What is the Assure® Titanium BGMS?
The Assure® Titanium BGMS is a next-generation blood glucose monitoring system designed for post-acute and long-term care settings.
How does the quality control lockout work?
This feature enforces daily quality control testing, ensuring that glucose readings are only taken from verified devices to enhance accuracy.
Who can benefit from using the Titanium BGMS?
Skilled nursing facilities, endocrinology clinics, and other post-acute providers can all benefit from the enhanced diabetes management capabilities of this system.
What support does ARKRAY offer for integration?
ARKRAY provides comprehensive training and implementation services to ensure seamless integration of the Titanium BGMS into existing workflows.
How long has ARKRAY been in the healthcare industry?
ARKRAY has been a pioneer in healthcare solutions for over fifty years, establishing itself as a leader in diabetes management technologies.
